ロード中...
依布替尼通过新型途径克服弥漫大B细胞淋巴瘤细胞耐药机制的研究
OBJECTIVE: To explore the mechanism of ibrutinib on drug resistance diffuse large B-cell lymphoma (DLBCL) cells. METHODS: DLBCL cell line was cultured with mesenchymal stem cells (MSC), and DLBCL cells which migrated and adhered to MSC under microscope was counted. The secretion of CXCL12 by MSC wer...
保存先:
| 出版年: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Editorial office of Chinese Journal of Hematology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342183/ https://ncbi.nlm.nih.gov/pubmed/29365396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|